BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today announced an investment of over $6 million to expand ...
Companies developing 505(b)(2), NDA, ANDA, branded or generic prescription drug products are encouraged to explore LGM Pharma’s expanded manufacturing capabilities by visiting LGMPharma.com or ...